Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf”, “OILS”, or the “Company”), the world’s most innovative cannabis processor, is pleased to provide shareholders with the following corporate update:

Nextleaf Comments on Financial Results from Q1 Financials

First quarter 2021 represents Nextleaf’s first full quarter generating processing revenue, with the company commencing cannabis wholesale revenue in September 2020. Nextleaf is pleased to announce record revenue (unaudited) of $1,257,000 during the quarter ended December 2020. The revenue figure represents a 359% increase year-over-year for the same period. The Company delivered bulk sales of approximately 100 kilos of high-purity CBD distillate to a British Columbia-based licensed producer and distributor of cannabis products. During the quarter, Nextleaf continued to add to its client roster, signing cannabis extraction agreements with three Canadian licensed producers which operate cannabis production and distribution facilities across Canada.

The industry continues to see demand for efficient extraction and distillation services due to an ample supply across the industry of dried cannabis biomass that has a shorter shelf life than cannabis oils. The Company expects to continue to announce additional commercial contracts through fiscal 2021, with a focus on building on existing clients to expand from one-off supply orders to longer term supply agreements. Nextleaf has the ability to fully leverage its low-cost extraction and distillation platform by increasing its plant utilization to drive wholesale revenue.

Nextleaf Receives Mexican Patent

The Mexican Institute of Industrial Property has granted Nextleaf a patent vital to the low-cost production of cannabis distillate. Nextleaf owns the second largest cannabis patent portfolio in Mexico.

On September 19, 2020 the Mexican Senate approved a comprehensive adult-use marijuana legalization bill. The pending law requires President Andrés Manuel López Obrador signing the bill into law, which will make Mexico the third country to legalize adult-use cannabis. Mexico’s supreme court recently set a deadline of April 30, 2021 for the law to be passed. Once signed, Mexico will become the largest legal cannabis market in the world, based on population.

Nextleaf has developed a competitive advantage through technology that is protected in key countries, including Canada, the United States, Israel, Australia, New Zealand, Mexico, Colombia, South Africa, the U.K., and across Europe.

CBD Gummies Powered by OILS™ now Available in B.C.

CBD gummies powered by OILS™ high purity CBD distillate were launched at cannabis retailers in British Columbia through the Company’s Commercial Partners Program. This marks an important milestone for Nextleaf in the commercialization of its intellectual property (“IP“) portfolio, as the Company continues to expand its wholesale customer base.

Rapid Emulsion Technology by OILS™

Nextleaf completed production of its first commercial batch of rapid THC oil drops using the Company’s patent pending rapid emulsification technology. With a development focus of providing a rapid onset, Nextleaf’s proprietary delivery technology allows its private label partners to develop differentiated cannabis ingestible products. Looking ahead, the Company sees increased opportunities to monetize its delivery technology into higher margin private label business.

General Market Outlook

The cannabis oil segment has experienced hyper commoditization over the past two years and although the rate is slowing, the segment will continue to face pricing pressure, as the market moves toward equilibrium in supply and demand.

Nextleaf is uniquely positioned to be a low-cost leader based on the simple, yet powerful, fact that its technology was built around converting the lowest cost input into high-purity distillate. Due to a focus on automation, as Nextleaf’s facility utilization increases – further operational synergies should be realized, providing the ability to drive costs down and provide more value to B2B clients.

“We’ve built our entire business to deliver efficient value to our clients through innovation. Furthermore, we’ve structured many of our supply agreements to leverage a split revenue model, providing a hedge on commodity risk – one of the largest enterprise risks faced by all cannabis companies,” said Nextleaf Solutions CFO Charles Ackerman. “As the overall consumer market continues to grow steadily with the rollout of retail stores and broader product offerings, we expect to see the industry work through the market oversupply. We believe that ultimately, the companies that continue to innovate and drive further value for clients, like Nextleaf, will be the long term winners in this industry,” said Ackerman.

About Nextleaf®

Nextleaf is an innovative cannabis processor that owns one of the largest portfolios of U.S. patents for the extraction, purification, and delivery of cannabinoids. Through its wholly-owned subsidiary Nextleaf Labs Ltd, a licensed processor, the Company is a low-cost producer of cannabis distillate and private label THC & CBD oils. Nextleaf’s proprietary closed-loop automated extraction plant in Metro Vancouver has a design capacity to process 600 kilos of dried cannabis into oil per day. The Company owns 12 U.S. patents and has been issued over 70 patents globally. Nextleaf is developing delivery technology through its Health Canada research licence, including sensory evaluation of cannabis via human testing. The Company’s patent pending Rapid Emulsion Technology by OILS™ powers differentiated ingestible cannabis products. Nextleaf is commercializing its issued and pending patents through licensing of intellectual property, providing extraction services, and supplying cannabis oils to qualified Canadian and international business-to-business partners under their own brand.

Nextleaf Solutions trades as OILS on the Canadian Securities Exchange, OILFF on the OTCQB Market in the United States, and L0MA on the Frankfurt Stock Exchange.

Follow OILS across social media platforms: Twitter, LinkedIn, Facebook, and Instagram.

For more information please contact:
Jason McBride
604-283-2301 (ext. 219)

On behalf of the Board of Directors of the Company,

Paul Pedersen, CEO

Certain statements contained in this press release constitute “forward-looking statements”. All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the Company’s ability to capitalize on its IP portfolio, the Company’s strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”, “project”, “seek”, “should” or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company’s expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company’s MD&A for the most recent fiscal period. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law. The CSE has not reviewed or approved the contents of this press release.

To view the source version of this press release, please visit

News Provided by Newsfile via QuoteMedia

  • Company has received UK Continuing Professional Development (“CPD”) accreditation for its global education platform, Khiron Academy
  • UK medical professionals may now earn CPD credits through Khiron’s medical cannabis education program
  • The Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK, to increase patient access via medical cannabis education
  • As a leading international medical cannabis educator, nearly 1,000 medical professionals in Latin America and the United Kingdom have registered for, or completed, Khiron Academy training

 Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe is pleased to announce it has received UK Continuing Professional Development (“CPD”) accreditation for Khiron Academy, the Company’s global medical cannabis education platform.

Additionally, following its accreditation, the Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK and fellow founding member of Project Twenty21, to increase patient access through medical cannabis education initially. Khiron Academy will be made available to prescribers in the UK that have registered with Cellen’s MedCanHub, an emerging education portal. Cellen is market leader, widely recognized for also launching the UK’s first digital pain clinic, Leva.

Keep reading... Show less

TRACE’s plant-based and alkaline wellness products to expand into key markets of Japan, China and the Philippines

Emerging leader in innovative health and wellness beverages and consumer products, BevCanna Enterprises Inc . ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today its anticipated expansion into the Asia Pacific region, through its wholly-owned subsidiary Naturo Group. After completing a comprehensive market, distribution and partner assessment, the Company intends to initially launch its portfolio of TRACE health and wellness products in the key markets of Japan, China, and the Philippines, through multi-channel distribution outlets including e-commerce, retail, and wholesale.

Keep reading... Show less

Trulieve acquires dispensary permits from Solevo Wellness West Virginia LLC for $650,000

Trulieve Cannabis Corp . (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States and the largest cannabis company in Florida announced today that it acquired Solevo Wellness West Virginia LLC (“Solevo”) and its three West Virginia dispensary permits for $650,000 . Solevo was awarded two permits in Morgantown and one in Parkersburg in January 2021 as part of the West Virginia application process.

Keep reading... Show less

Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”) a wellness company that develops and sells sustainable, plant-based products, is pleased to announce that it’s Jusu Home and Body line is now available for purchase on Faire Wholesale Marketplace (“Faire” or “”), an online wholesale marketplace valued at US $2.5 billion. Jusu Home and Body products are currently featured in their “New Arrivals” section.

Cannot view this image? Visit:

Keep reading... Show less

 Aion Therapeutic Inc. (CSE: AION) (” Aion Therapeutic ” or the ” Company “) today announced that it has retained KCSA Strategic Communications (” KCSA “), a leading New York City -based communications firm.

Keep reading... Show less